Deleted Tweets From Scott Gottlieb, R-D.C.

I know and admire Dr. Redfield and I am delighted to be partnering with him and continuing #FDA’s close collaboration with the entire team @CDCgov to advance our shared public health goals. https://t.co/oUeEnBICyN QT @SecAzar: Today I swore in Dr. Robert Redfield as the 18th Director of @CDCgov. He has dedicated his entire life to promoting… https://t.co/0BNqwwCjpy)

RT @CDCgov: Store perishable fresh fruits and vegetables at 40° F or below. Use a refrigerator thermometer to check!… https://t.co/DbL2A7ihqK

Check out upcoming #FDAOncology stakeholder meetings https://t.co/G167V0ZXFV https://t.co/F3jXCErgHQ

Track the major #FDA #cancer #drugapprovals with our list: https://t.co/jKmy2B0wk1

RT @CDCDirector: This is Dr. Redfield tweeting from @CDCDirector. I’m grateful to be at CDC and looking forward to sharing info with you here.

RT @FDAOncology: Watch @FDAOncology Pazdur on importance of communication among all parties in expanded access https://t.co/F8nY97WFUB @reaganudall

RT @RAPSorg: .@US_FDA Offers Glimpse into New Work in #MedDevice #Cybersecurity, #3DPrinting, Artificial Intelligence |… https://t.co/fbWtylNsKV

RT @RAPSorg: .@US_FDA Finalizes Guidance on PRO Assessment Tool for #COPD Trials | #Regulatory Focus https://t.co/xPUjdee2br… https://t.co/QqNCjDqqS3

RT @saveantibiotics: Health care professionals used to have to rely on old data to confirm whether or not an #antibiotic would work for… https://t.co/CtcpfnZRYb

#FDA shares the belief that tobacco products, including e-cigs, should never be marketed to, sold to, or used by kids and the agency will be taking new steps soon to help keep kids from using tobacco products

#FDA needs to develop the foundational regulations that will define a rigorous process for the proper review of products that could pose far less risk than combusting tobacco for ADULTS who still want access to satisfying levels of nicotine

Part of #FDA’s policy recognizes nicotine exists on a continuum of risk; including in pharmaceutical products sold over the counter. In our framework, we’re advancing rules laying out a path for pre-market review of nicotine products that could pose less

At the same time #FDA is advancing new policies that put nicotine at the center of our regulatory efforts; and we’re proposing to render combustible cigarettes minimally or non addictive to dramatically lower smoking rates in the U.S.

#FDA takes use of e-cigs by youth very seriously. We’ll continue to enforce laws, including those aimed at preventing inappropriate targeting of kids and prohibiting retailers from selling tobacco products, including e-cigs, to minors; and will take new a

We’re committed to advancing our comprehensive policy to significantly reduce tobacco related disease & death, and prevent youth use of tobacco. Learn more about #FDA’s comprehensive plan for tobacco and nicotine regulation https://t.co/yepZuPinfx

As a part of our plan, #FDA is also focused on advancing product innovation when it comes to over the counter nicotine products that can help smokers quit and stay quit; and we have comprehensive, new policy we’ll announce soon

RT @FDAOncology: #FDA issued final #guidance for industry on BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs an… https://t.co/Iakwhjnnox

RT @US_FDA: FDA has developed a model that estimates the amount of blood available in the U.S. during both routine conditions a… https://t.co/WTmqAbtt0s

RT @SecAzar: Glad to see @Aetna lowering drug costs for patients and families. #Transparency is key to lowering healthcare costs… https://t.co/Emzdu1CIiD

My interview with @TheEconomist on ways #FDA is advancing new policies aimed at helping to make drug R&D more efficient; improving patient access to new, safe and effective treatments https://t.co/qfrZRddHYf

I know and admire Dr. Redfield and I am delighted to be partnering with him and continuing #FDA’s close collaboration with the entire team @CDCgov to advance our shared public health goals. https://t.co/oUeEnBICyN QT @SecAzar: Today I swore in Dr. Robert Redfield as the 18th Director of @CDCgov. He has dedicated his entire life to promoting… https://t.co/0BNqwwCjpy)

RT @CDCgov: Store perishable fresh fruits and vegetables at 40° F or below. Use a refrigerator thermometer to check!… https://t.co/DbL2A7ihqK

Check out upcoming #FDAOncology stakeholder meetings https://t.co/G167V0ZXFV https://t.co/F3jXCErgHQ

Track the major #FDA #cancer #drugapprovals with our list: https://t.co/jKmy2B0wk1

RT @CDCDirector: This is Dr. Redfield tweeting from @CDCDirector. I’m grateful to be at CDC and looking forward to sharing info with you here.

RT @FDAOncology: Watch @FDAOncology Pazdur on importance of communication among all parties in expanded access https://t.co/F8nY97WFUB @reaganudall

RT @RAPSorg: .@US_FDA Offers Glimpse into New Work in #MedDevice #Cybersecurity, #3DPrinting, Artificial Intelligence |… https://t.co/fbWtylNsKV

RT @RAPSorg: .@US_FDA Finalizes Guidance on PRO Assessment Tool for #COPD Trials | #Regulatory Focus https://t.co/xPUjdee2br… https://t.co/QqNCjDqqS3

RT @saveantibiotics: Health care professionals used to have to rely on old data to confirm whether or not an #antibiotic would work for… https://t.co/CtcpfnZRYb

#FDA shares the belief that tobacco products, including e-cigs, should never be marketed to, sold to, or used by kids and the agency will be taking new steps soon to help keep kids from using tobacco products

#FDA needs to develop the foundational regulations that will define a rigorous process for the proper review of products that could pose far less risk than combusting tobacco for ADULTS who still want access to satisfying levels of nicotine

Part of #FDA’s policy recognizes nicotine exists on a continuum of risk; including in pharmaceutical products sold over the counter. In our framework, we’re advancing rules laying out a path for pre-market review of nicotine products that could pose less

At the same time #FDA is advancing new policies that put nicotine at the center of our regulatory efforts; and we’re proposing to render combustible cigarettes minimally or non addictive to dramatically lower smoking rates in the U.S.

#FDA takes use of e-cigs by youth very seriously. We’ll continue to enforce laws, including those aimed at preventing inappropriate targeting of kids and prohibiting retailers from selling tobacco products, including e-cigs, to minors; and will take new a

We’re committed to advancing our comprehensive policy to significantly reduce tobacco related disease & death, and prevent youth use of tobacco. Learn more about #FDA’s comprehensive plan for tobacco and nicotine regulation https://t.co/yepZuPinfx

As a part of our plan, #FDA is also focused on advancing product innovation when it comes to over the counter nicotine products that can help smokers quit and stay quit; and we have comprehensive, new policy we’ll announce soon

RT @FDAOncology: #FDA issued final #guidance for industry on BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs an… https://t.co/Iakwhjnnox

RT @US_FDA: FDA has developed a model that estimates the amount of blood available in the U.S. during both routine conditions a… https://t.co/WTmqAbtt0s

RT @SecAzar: Glad to see @Aetna lowering drug costs for patients and families. #Transparency is key to lowering healthcare costs… https://t.co/Emzdu1CIiD

My interview with @TheEconomist on ways #FDA is advancing new policies aimed at helping to make drug R&D more efficient; improving patient access to new, safe and effective treatments https://t.co/qfrZRddHYf